Regent Pacific Group Limited (HKG:0575)
0.7300
-0.0200 (-2.67%)
Sep 9, 2025, 9:47 AM HKT
Regent Pacific Group Revenue
Regent Pacific Group had revenue of $237.00K USD in the half year ending June 30, 2025, a decrease of -16.25%. This brings the company's revenue in the last twelve months to $833.00K, up 1,533.33% year-over-year. In the year 2024, Regent Pacific Group had annual revenue of $719.00K with 147.08% growth.
Revenue (ttm)
$833.00K
Revenue Growth
+1,533.33%
P/S Ratio
33.47
Revenue / Employee
$49.00K
Employees
17
Market Cap
218.86M HKD
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 719.00K | 428.00K | 147.08% |
Dec 31, 2023 | 291.00K | 177.00K | 155.26% |
Dec 31, 2022 | 114.00K | -3.14M | -96.50% |
Dec 31, 2021 | 3.25M | 1.58M | 94.85% |
Dec 31, 2020 | 1.67M | 1.51M | 918.29% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeOne Medicines AG | 35.81B |
Hansoh Pharmaceutical Group Company | 14.45B |
JD Health International | 71.34B |
Innovent Biologics | 12.52B |
Sino Biopharmaceutical | 33.49B |
WuXi Biologics | 21.98B |
Akeso | 2.75B |
CSPC Pharmaceutical Group | 28.49B |